Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

UroGen Pharma (URGN) Asset Utilization Ratio (2019 - 2025)

UroGen Pharma (URGN) has disclosed Asset Utilization Ratio for 7 consecutive years, with 0.57 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Asset Utilization Ratio rose 85.14% year-over-year to 0.57, compared with a TTM value of 0.57 through Dec 2025, up 85.14%, and an annual FY2025 reading of 0.45, up 15.92% over the prior year.
  • Asset Utilization Ratio was 0.57 for Q4 2025 at UroGen Pharma, up from 0.49 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.7 in Q2 2023 and bottomed at 0.18 in Q1 2021.
  • Average Asset Utilization Ratio over 5 years is 0.41, with a median of 0.4 recorded in 2022.
  • The sharpest move saw Asset Utilization Ratio surged 180222.4% in 2021, then crashed 49.38% in 2024.
  • Year by year, Asset Utilization Ratio stood at 0.38 in 2021, then grew by 29.02% to 0.49 in 2022, then decreased by 8.75% to 0.44 in 2023, then tumbled by 30.83% to 0.31 in 2024, then skyrocketed by 85.14% to 0.57 in 2025.
  • Business Quant data shows Asset Utilization Ratio for URGN at 0.57 in Q4 2025, 0.49 in Q3 2025, and 0.41 in Q2 2025.